Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
NETSOL Technologies, Inc. announced the appointment of Michael Ramsey as Vice President of Sales for its Transcend Finance platform in the Americas. Ramsey brings over 30 years of experience in asset finance enterprise sales and will lead growth initiatives in the U.S., the largest asset finance market globally. This strategic hire aligns with NETS…
Hyperion DeFi, Inc. announced repurchasing over 240,000 shares at a $3.21 average price, fully retiring $8.6 million of legacy debt, and positioning itself for further capital structure optimization. The company aims to leverage its debt-free status and $14.5 million in cash and equivalents to scale its Hyperliquid blockchain ecosystem and DeFi ope…
Teva Pharmaceuticals disclosed new data demonstrating that ecopipam, their investigational treatment for pediatric Tourette syndrome, shows significant tic severity reduction in about 70% of patients within 8 weeks and sustained efficacy with no new safety concerns during long-term follow-up. The drug's efficacy is unaffected by common co-occurring…
Teva Pharmaceuticals announced a comprehensive review published in the Journal of Child Neurology that details the role of dopamine in Tourette syndrome and presents ecopipam, an investigational selective D1 receptor antagonist, as a differentiated and potentially safer treatment for pediatric patients. Data from Phase 2 and 3 trials demonstrate ec…
ServiceNow is executing a profitable pivot: embedding AI across the Now Platform is lifting deal sizes, accelerating revenue growth and improving monetization. The stock still looks like a 'strong buy' for investors willing to accept a premium multiple while AI adoption scales.
Sezzle is trading at $109.73 after a string of product launches and merchant additions that pushed Q2 growth and marketing ROI higher. With revenue growing 51.7% year-over-year, free cash flow of $327.6M and expanding merchant partnerships, the setup favors a mid-term long swing. Entry $109.73, target $145.00, stop $95.00 - horizon 45 trading days.
A scheduled OPEC+ production capacity review that was to establish 2027 output quotas has been postponed to mid-November. The delay follows disruptions to capacity expansion projects across the Middle East stemming from the US-Israeli war on Iran, and several member states have not provided required data, complicating an independent assessment of s…
Boeing's surprise win of the F/A-XX program is a material positive for BA's defense franchise and a short-term shock to competitor Northrop. The award should lift Boeing's backlog, drive near-term defense revenue upside and boost investor confidence in program execution. We recommend a tactical long in BA with a clearly defined stop and target over…
Autodesk's subscription-first business is delivering predictable free cash flow and accelerating AI-driven product value in construction and manufacturing. At $214.20 the market is discounting growth momentum and optionality from generative AI; we recommend a long with a $280 target and a $185.50 stop on a 180-trading-day thesis.
National Energy Services Reunited (NESR) is executing a profitable Middle East expansion driven by the Jafurah ramp-up and a 3B3 growth strategy. With Q2 2026 revenue momentum, improving adjusted EBITDA and a clear $3 billion run-rate target, NESR looks positioned to re-rate from a growth/energy-services multiple. I recommend a long trade with disc…
InflaRx announced its selection for a late-breaking poster session at Kidney Week 2026 to present pre-clinical data on izicopan, an oral C5a receptor antagonist showing therapeutic potential in kidney disease models. Izicopan has demonstrated favorable safety, pharmacokinetics, and efficacy profiles in Phase 1 and 2a studies in inflammatory disease…
Cytokinetics announced four presentations at the 2026 HFSA Annual Scientific Meeting highlighting clinical trial results of aficamten, a cardiac myosin inhibitor for hypertrophic cardiomyopathy (HCM). These presentations include late-breaking data from the ACACIA-HCM and SEQUOIA-HCM trials, emphasizing aficamten's efficacy and safety in non-obstruc…
Aura Minerals announced an agreement to acquire the mining fleet operations currently outsourced to third parties at its Brazilian gold mines Apoena, Almas, and Borborema. This insourcing, planned for January 2027, is expected to reduce all-in sustaining costs by $150-200 per ounce, improve equipment reliability, and provide greater operational con…
Factorial Energy has credible technology that could reshape battery safety and energy density, but commercial traction and consistent manufacturing economics remain unproven. This trade idea outlines a long position sized for high risk / high reward, anchored to a clear entry, stop and target—and a 180 trading day timeline to see pilot-to-scale pro…
An OPEC+ review intended to establish members' sustainable production capacities for setting 2027 quotas has been pushed back after the US-Israeli war on Iran interrupted planned capacity-expansion projects across the Middle East. The review, originally ordered for late 2025 with a completion target by the end of September 2026, has seen its deadli…
Hub Group, Inc. announced major changes to its Board of Directors following a consent action by controlling shareholders, appointing four new directors and removing three without cause. The company also adopted amended bylaws and is actively appealing Nasdaq's decision to initiate delisting due to delayed financial filings. The changes aim to reinf…
RTX is being fed a fresh stream of defense orders — market chatter and company-related reports indicate roughly $45 billion of new awards and multiyear production deals. With a $249 billion market cap, solid free cash flow ($11.4B last reported), and an oversold technical backdrop, this is a tactical long for investors willing to accept program exe…
Rogers Communications partners with Live Nation Canada to present the Backstreet Boys' only 2027 North American stadium shows, offering exclusive presale and premium experiences to Rogers customers. The concert residency celebrates the seminal 'Millennium' album and strengthens Rogers' entertainment portfolio, enhancing customer loyalty and engagem…
Pyxis Oncology, a clinical-stage biopharmaceutical company, has closed a public offering generating approximately $110 million in upfront proceeds, with the potential to raise an additional $172.6 million through exercise of milestone-linked warrants. The funds will support the advancement of its lead drug candidate, micvotabart pelidotin (MICVO), …
CECO Environmental Corp. announced its Board has approved transferring its primary stock listing from Nasdaq to the Texas Stock Exchange (TXSE), effective October 19, 2026. The company will retain its ticker symbol 'CECO' and CUSIP without impacting operations or shareholder rights. The move aims to strengthen the company's alignment with Texas's d…
Yara International (YARIY) offers a low-risk entry into a commodity-exposed fertilizer leader with a cheap valuation, a 3.8% yield, and an improving capital structure. The trade: buy at $21.70, stop at $19.50, target $28.00 over a mid-term (45 trading days) horizon. Thesis rests on U.S. project optionality, partnership momentum with Air Products, a…
Nebius has moved from niche vendor to mission-critical infrastructure partner for generative and agentic AI. Strong top-line momentum, ownership of data centers, and a $40 billion backlog position the company to capture outsized pricing power. This trade idea lays out an entry at $235, a stop at $210 and a $320 target over a 45-trading-day swing wh…
Nova Minerals Corp invites investors to a webinar to discuss recent advancements at its Estelle Gold and Critical Minerals Project in Alaska and new capabilities in antimony processing and refining at Port MacKenzie. The company's efforts are supported by a $43.4 million award from the U.S. Department of War to establish a secure domestic antimony …
We like a tactical long in IHRT into H2 2026 to capture an expected record political advertising cadence and related EBITDA leverage. The stock trades near its 52-week low at $2.10, with an EV/EBITDA of 9.5x and free cash flow of $36.3M. The balance sheet and legacy leverage keep risk high, but near-term cash generation and acquisition chatter crea…
Itochu (ITOCY) looks positioned to accelerate capital deployment and benefit from renewed investor interest in Japanese trading houses. Market cap sits at ~$109.6B, P/E 16.7 and dividend yield ~1.25% — valuations that can re-rate with visible buyback/capital-return activity and macro tailwinds. This is a swing trade to capture that re-rating over t…
